Identification of proteomic biomarkers of preeclampsia using protein microarray and tandem mass spectrometry

Journal Title: Advances in Hygiene and Experimental Medicine - Year 2015, Vol 69, Issue 0

Abstract

Preeclampsia (PE) is the leading cause of death of the fetus and the mother. The exact pathomechanism has not so far been clarified. PE coexists with many other diseases, but it is often difficult to explain the association between them and find a clear reason for their occurrence. There are many predictive factors, but none are highly specific in preeclampsia. The diagnosis of preeclampsia seems to be very complex, which is another argument for the exploration of knowledge on this subject. Although many of the discoveries have hitherto been made in the field of proteomics, still no single specific biomarker of preeclampsia has been discovered. Research at the genome level is important because it can help us understand the genetic predisposition of patients affected by this disease. Nevertheless, researchers have recently become more interested in the pathophysiology of PE, and they are trying to answer the question: what is the real, direct cause of preeclampsia? Thus, the discovery of a protein that is a good predictor of preeclampsia development would significantly accelerate the medical care of pregnant women, and consequently reduce the risk of occurrence of HELLP syndrome and fetal death. Apart from the predictive and diagnostic function, such a discovery would help us to better understand the pathogenesis of preeclampsia and to find in the future a medical drug to suppress this disease. In order to make a breakthrough in this field, scientists need to use the most modern methods of proteomics, which allow for the analysis of small amounts of biological material in the shortest possible time, thereby giving a lot of information about existing proteins in the sample. Such optimization allows two methods, most commonly used by researchers: tandem mass spectrometry and protein microarray technique.

Authors and Affiliations

Karol Charkiewicz, Elwira Jasinska, Piotr Laudanski

Keywords

Related Articles

Cyclic guanosine monophosphate in the regulation of the cell function

Intracellular concentration of cGMP depends on the activity of guanylate cyclase, responsible for its synthesis, on the activity of cyclic nucleotide degrading enzymes - phosphodiesterases (PDEs). There are two forms of...

Seladyna 1/DHCR24: główne białko homeostazy komórkowej i biosyntezy cholesterolu

Seladyna 1 (produkt genu DHCR24) jest wielofunkcyjnym białkiem, którego właściwości enzymatyczne, antyoksydacyjne i antyapoptotyczne sprawiają, że stanowi ono istotny czynnik neuroprotekcyjny. Białko to zidentyfikowano w...

Sprzężone trieny kwasu linolenowego (conjugated linolenic acid – CLnA, super CLA) – źródła i działanie biologiczne

Wielonienasycone kwasy tłuszczowe (WNKT) charakteryzują się wielokierunkową aktywnością biologiczną. Wśród nich szczególne zainteresowanie badaczy budzą kwasy zawierające w łańcuchu węglowym układ sprzężonych wiązań podw...

The cellular receptors of exogenous RNA

One of the key determinants of survival for organisms is proper recognition of exogenous and endogenous nucleic acids. Therefore, high eukaryotes developed a number of receptors that allow for discrimination between frie...

Download PDF file
  • EP ID EP67683
  • DOI -
  • Views 149
  • Downloads 0

How To Cite

Karol Charkiewicz, Elwira Jasinska, Piotr Laudanski (2015). Identification of proteomic biomarkers of preeclampsia using protein microarray and tandem mass spectrometry. Advances in Hygiene and Experimental Medicine, 69(0), 562-570. https://europub.co.uk/articles/-A-67683